Lovelace Scientific Resources

Sarasota, Florida 34292

0 studies enrolling now · 17 studies all time

What they study most

Arthritis, Blood Pressure, High, Cognition Disorders, Epilepsy, Hypertension, Irritable Bowel Syndrome, Multiple Sclerosis, Osteoarthritis, Partial Epilepsy, Refractory Partial Seizures, Relapsing Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis

Studies at this site

• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
• Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip — Stopped early
• Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures — Completed
• A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab — Stopped early
• Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial — Completed
• Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures — Completed
• New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis — Completed
• Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission — Completed
• A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors — Completed
• Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3) — Completed
• Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy — Completed
• Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis — Completed
• Autologous T Cell Vaccine (TCV) for Multiple Sclerosis — Completed
• Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension — Completed
• Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome — Completed
• Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1) — Completed
• A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis — Completed